James Baber

Medicine · Health Sciences

14h-index1.4kcitations22works39.52yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antimicrobial Resistance in Staphylococcus(12), Bacterial Infections and Vaccines(6), Respiratory viral infections research(6), Influenza Virus Research Studies(3), Bacterial biofilms and quorum sensing(3)

Publications22 total

Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial
Obstetrics and Gynecology·2025· 62 citedOpen Access
Efficacy and safety of bivalent RSVpreF maternal vaccination to prevent RSV illness in Japanese infants: Subset analysis from the pivotal randomized phase 3 MATISSE trial
Vaccine·2024· 17 citedOpen Access
1941. Coadministration of Bivalent Respiratory Syncytial Virus (RSVpreF) Vaccine With Influenza Vaccine in Older Adults
Open Forum Infectious Diseases·2023Open Access
Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults
Clinical Infectious Diseases·2023· 39 citedOpen Access
Efficacy of a 4-Antigen <i>Staphylococcus aureus</i> Vaccine in Spinal Surgery: The <i>STaphylococcus aureus</i> suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial
Clinical Infectious Diseases·2023· 35 citedOpen Access
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants
New England Journal of Medicine·2023· 851 citedOpen Access
A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults
The Journal of Infectious Diseases·2022· 44 citedOpen Access
A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults
Nature Communications·2021· 30 citedOpen Access
Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel Staphylococcus aureus 4-Antigen Vaccine (SA4Ag)
Open Forum Infectious Diseases·2019· 20 citedOpen Access
S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccine
Journal of Infection·2019· 8 cited
The development of a staphylococcus aureus four antigen vaccine for use prior to elective orthopedic surgery
Human Vaccines & Immunotherapeutics·2018· 22 citedOpen Access
Safety, tolerability, and immunogenicity of a novel 4-antigen <i>Staphylococcus aureus</i> vaccine (SA4Ag) in healthy Japanese adults
Human Vaccines & Immunotherapeutics·2018· 14 citedOpen Access
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of a Four-Antigen Vaccine for Staphylococcus Aureus in Adults Prior to Open Posterior Spinal Fusion Surgery
The Spine Journal·2017· 1 cited
Vaccine development to prevent<i>Staphylococcus aureus</i>surgical-site infections
British journal of surgery·2017· 29 citedOpen Access
Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study
Vaccine·2016· 62 citedOpen Access
Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial
Vaccine·2016· 53 citedOpen Access
Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 study
Journal of Infection·2016· 11 cited
The Dynamics of Staphylococcus aureus carriage and Comparisons by Age in Two Studies of an Investigational S aureus 4-Antigen Vaccine (SA4Ag)
Open Forum Infectious Diseases·2016Open Access
A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults
Vaccine·2015· 58 citedOpen Access
Safety, Tolerability and Immunogenicity of a Single Dose 4-Antigen or 3-Antigen Staphylococcus aureus Vaccine in Healthy Older Adults
Open Forum Infectious Diseases·2015Open Access
page 1 of 2Next →

Frequent Co-authors

Annaliesa S. Anderson(17), William C. Gruber(15), David Cooper(13), Alejandra Gurtman(13), Kathrin U. Jansen(10), Joseph Eiden(9), Edward T. Zito(7), Peter Richmond(6), Kena A. Swanson(6), Qin Jiang(6), Kathrin U. Jansen(6), Robert W. Frenck(6), C. Buddy Creech(6), Joseph M. Severs(6), Douglas Girgenti(6), Martin Kankam(5), Anna Jaques(5), Iona Munjal(4), David Radley(4), Elena Kalinina(4)